Szabó I, Drozgyik I, Novák P, Bódis J, Csaba I
Z Geburtshilfe Perinatol. 1982 Feb;186(1):31-6.
In the course of investigations in pregnant rats the authors established that the effect of prednisolone-sodium succinate on the maturation of the fetal lung depends on the dose administered and/or on the time at which it was given. The prednisolone only increased the surface-active lecithin concentration - thus accelerating the functional maturation of the lung - if it was given on the 17th or 18th day of gestation, in a dose of 1.0 mg/kg or 2.0 mg/kg. A dose of 0.5 mg/kg had no effect, while a high dose not only inhibited lecithin synthesis but also caused significant side-effects. The authors point out that the glucocorticoids only have a favorable effect on lung maturation if administered during a certain period in their development, and link this to the maturation process of the specific cortisol receptors in the lung. They also point out the potential danger of glucocorticoids administered to prevent dyspnea and emphasize the importance of determining the lowest effective dose of the various synthetic preparations and/or the optimum time for giving them. They raise the question of whether there is also an ideal time for glucocorticoid treatment in human pregnancies.
在对怀孕大鼠的研究过程中,作者发现琥珀酸钠泼尼松龙对胎儿肺成熟的影响取决于给药剂量和/或给药时间。只有在妊娠第17或18天,以1.0毫克/千克或2.0毫克/千克的剂量给予泼尼松龙时,才会增加表面活性卵磷脂浓度,从而加速肺的功能成熟。0.5毫克/千克的剂量没有效果,而高剂量不仅会抑制卵磷脂合成,还会引起明显的副作用。作者指出,糖皮质激素只有在肺部发育的特定时期给药才对肺成熟有有利影响,并将此与肺中特定皮质醇受体的成熟过程联系起来。他们还指出了为预防呼吸困难而使用糖皮质激素的潜在危险,并强调确定各种合成制剂的最低有效剂量和/或给药最佳时间的重要性。他们提出了在人类妊娠中糖皮质激素治疗是否也存在理想时间的问题。